Ranitidine
- Product NDC
- 0615-4513
- 11-digit product format
- 006154513
- Labeler code
- 0615
- Product ID
- 0615-4513_40dc2a98-5890-49c8-8299-be9225d8fc8b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ranitidine
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- NCS HealthCare of KY, Inc dba Vangard Labs
- Application
- ANDA075165
- Marketing category
- ANDA
- Marketing start
- 2009-11-06
- Marketing end
- 0000-00-00
- Substance
- RANITIDINE HYDROCHLORIDE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0615-4513-05 | 2021-08-31 | C162847 | 48780-1 | 97449f38-d20b-f6ea-e053-dbdaa90aa703 | 0f026966-e6ed-4b5b-a8e4-1b383b010813 |
| 0615-4513-31 | 2021-08-31 | C162847 | 48780-1 | 97449f38-d20b-f6ea-e053-dbdaa90aa703 | 0f026966-e6ed-4b5b-a8e4-1b383b010813 |
| 0615-4513-39 | 2021-08-31 | C162847 | 48780-1 | 97449f38-d20b-f6ea-e053-dbdaa90aa703 | 0f026966-e6ed-4b5b-a8e4-1b383b010813 |
| 0615-4513-05 | 2019-11-13 | C162847 | 48780-1 | 97449f38-d20b-f6ea-e053-dbdaa90aa703 | 0f026966-e6ed-4b5b-a8e4-1b383b010813 |
| 0615-4513-31 | 2019-11-13 | C162847 | 48780-1 | 97449f38-d20b-f6ea-e053-dbdaa90aa703 | 0f026966-e6ed-4b5b-a8e4-1b383b010813 |
| 0615-4513-39 | 2019-11-13 | C162847 | 48780-1 | 97449f38-d20b-f6ea-e053-dbdaa90aa703 | 0f026966-e6ed-4b5b-a8e4-1b383b010813 |